Abstract
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antitubercular Agents
-
Drug Resistance, Multiple, Bacterial*
-
Humans
-
Mycobacterium tuberculosis / drug effects*
-
Peru / epidemiology
-
Retrospective Studies
-
Time Factors
-
Treatment Outcome
-
Tuberculosis / drug therapy*
-
Tuberculosis / epidemiology
-
Tuberculosis / microbiology*